Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats

International Journal of Molecular Medicine

Volumn 17, Issue 3, 2006, Pages 503-509

  Kusumoto, Kazunori ^a   Ido, Akio ^b   Moriuchi, Akihiro ^b   Katsura, Toshiya ^b   Kim, Ildeok ^b   Takahama, Yuka ^a   Numata, Masatsugu ^a   Kodama, Mayumi ^a   Hasuike, Satoru ^a   Nagata, Kenji ^a   Uto, Hirofumi ^a   Inui, Ken Ichi ^b   Tsubouchi, Hirohito ^a,b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Albuminuria; Hepatocyte growth factor; Liver cirrhosis; Pharmacokinetics

Indexed keywords

ALANINE AMINOTRANSFERASE; DIMETHYLNITROSAMINE; RECOMBINANT PROTEIN; SCATTER FACTOR; SERUM ALBUMIN;

ALBUMINURIA; ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EXPERIMENTAL LIVER CIRRHOSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER REGENERATION; LIVER RESECTION; MALE; ORGAN SIZE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ALANINE TRANSAMINASE; ALBUMINURIA; ANIMALS; BODY WEIGHT; DIMETHYLNITROSAMINE; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HUMANS; INJECTIONS, INTRAVENOUS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER REGENERATION; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SERUM ALBUMIN;

EID: 33644940876     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.3.503     Document Type: Article

References (49)

1. Gohda E, Tsubouchi H, Nakayama H, et al: Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res 166: 139-150, 1986.
2. Gohda E, Tsubouchi H, Nakayama H, et al: Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81: 414-419, 1988. (Pubitemid 18075233)
3. Tsubouchi H, Niitani Y, Hirono S, et al: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13: 1-5, 1991.
4. Tsubouchi H, Kawakami S, Hirono S, et al: Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor. Lancet 340: 307, 1992.
5. Michalopoulos GK: Liver regeneration: molecular mechanisms of growth control. FASEB J 4: 176-185, 1990.
6. Dignass AU, Lynch-Devaney K and Podolsky DK: Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 202: 701-709, 1994. (Pubitemid 24259271)
7. Bussolino F, Di Renzo MF, Ziche M, et al: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641, 1992.
8. Zarneger R and Michalopoulos GK: The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129: 1177-1180, 1995.
9. Fujiwara K, Nagoshi S, Ohno A, et al: Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 18: 1443-1449, 1993. (Pubitemid 23348435)
10. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K and Nakamura T: Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16: 1227-1235, 1992.
11. Ishii T, Sato M, Sudo K, et al: Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem 117: 1105-1112, 1995.
12. Webber EM, Fitzgerald MJ, Brown PI, Barlett MH and Fausto N: Transforming growth factor-α expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-α and hepatocyte growth factor. Hepatology 18: 1422-1431, 1993. (Pubitemid 2003757)
13. Moriuchi A, Hirono S, Ido A, et al: Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes. Biochem Biophys Res Commun 280: 368-273, 2001.
14. Okano J, Shiota G and Kawasaki H: Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice. Hepatology 26: 1241-1249, 1997.
15. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y and Nakamura T: Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 244: 683-690, 1998.
16. Masunaga H, Fujise N, Shiota A, et al: Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries. Eur J Pharmacol 342: 267-279, 1998. (Pubitemid 28149979)
17. Kosai K, Matsumoto K, Funakoshi H and Nakamura T: Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure. Hepatology 30: 151-159, 1999. (Pubitemid 29300581)
18. Mori I, Tsuchida A, Taiji M and Noguchi H: Hepatocyte growth factor protects mice against anti-Fas antibody-induced death. Med Sci Res 27: 355-359, 1999. (Pubitemid 29253640)
19. Nomi T, Shiota G, Isono M, Sato K and Kawasaki H: Adenovirus-mediated hepatocyte growth factor gene transfer prevents lethal liver failure in rats. Biochem Biophys Res Commun 278: 338-343, 2000.
20. Xue F, Takahara T, Yata Y, et al: Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation. Gut 50: 558-562, 2002. (Pubitemid 34638878)
21. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T and Higashio K: Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24: 636-642, 1996.
22. Matsuda Y, Matsumoto K, Yamada A, et al: Prevention and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26: 81-89, 1997.
23. Ueki T, Kaneda Y, Tsutsui H, et al: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5: 226-230, 1999. (Pubitemid 29068532)
24. Sato M, Kakubari M, Kawamura M, Sugimoto J, Matsumoto K and Ishii T: The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced thioacetamide. Biochem Pharmacol 59: 681-690, 2000.
25. Oe S, Fukunaka Y, Hirose T, Yamaoka Y and Tabata Y: A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor. J Control Release 307: 146-151, 2003. (Pubitemid 36287337)
26. Ido A, Moriuchi A, Kim ID, et al: Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatol Res 30: 175-181, 2004.
27. Higgins GM and Anderson RM: Experimental pathology of the liver: restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12: 186-202, 1931.
28. Kawakami S, Tsubouchi H, Nakagawa S, et al: Expression of hepatocyte growth factor in normal and carbon tetrachloride-treated monkeys. Hepatology 20: 1255-1260, 1994. (Pubitemid 24980374)
29. Gohda E, Kataoka H, Tsubouchi H, Daikuhara Y and Yamamoto I: Phorbol ester-induced secretion of human hepatocyte growth factor by human skin fibroblasts and its inhibition by dexamethasone. FEBS Lett 301: 107-110, 1992.
30. Tamura M, Arakaki N, Tsubouchi H, Takada H and Daikuhara Y: Enhancement of human hepatocyte growth factor production by interleukin-1α ar-α by fibroblasts in culture. J Biol Chem 268: 8140-8145, 1993.
31. Gohda E, Takebe T, Sotani T, Nakamura S, Minowada J and Yamamoto I: Induction of hepatocyte growth factor by interleukin-γ in human leukemia cells. J Cell Physiol 174: 107-114, 1998.
32. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y and Kitamura N: Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem 268: 10024-10028, 1993.
33. Miyazawa K, Shimomura T, Naka D and Kitamura N: Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem 269: 8966-8970, 1994.
34. Miyazawa K, Shimomura T and Kitamura N: Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 271: 3615-3618, 1996.
35. Shimomura T, Miyazawa K, Komiyama Y, Hiraoka H, Naka D, Morimoto Y and Kitamura N: Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 229: 257-261, 1995.
36. Shimomura T, Denda K, Kitamura A, et al: Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 272: 6370-6376, 1997.
37. Kataoka H, Shimomura T, Kawaguchi T, et al: Hepatocyte growth factor activator inhibitor type-1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem 275: 40453-40462, 2000.
38. Yanagida H, Kaibori M, Hijikawa T, Kwon A-H, Kamiyama Y and Okumura T: Administration of rhHGF-activator via portal vein stimulates the regeneration of cirrhotic liver after partial hepatectomy in rats. J Surg Res doi:10.1016/j.jss.2005.08.002.
39. Ikeda H, Nagoshi S, Ohno A, Yanase M, Maekawa H and Fujiwara K: Activated stellate cells express c-met and respond to hepatocyte growth factor to enhance transforming growth factor β1 expression and DNA synthesis. Biochem Biophys Res Commun 250: 769-775, 1998.
40. Alcolado R, Arther MJP and Iredale JP: Pathogenesis of liver fibrosis. Clin Sci 92: 103-112, 1997.
41. Wu J and Zern MA: Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 35: 665-672, 2000.
42. Tuchweber B, Desmouliere A, Bochaton-Piallat ML, Rubbia Brandt L and Gabiani G: Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rats. Lab Invest 74: 265-278, 1996.
43. Knittel T, Kobold D, Saile B, Grundmann A, Neubauer K, Piscaglia F and Ramadori G: Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibronogenic potential. Gastroenterology 117: 1205-1221, 1999.
44. Ozaki I, Zhao G, Mizuta T, et al: Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol 36: 169-178, 2002.
45. Kim W-H, Matsumoto K, Bessho K and Nakamura T: Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 166: 1017-1028, 2005.
46. Liu KX, Kato Y, Narukawa M, et al: Importance of the liver in plasma clearance of hepatocyte growth factor in rats. Am J Physiol 263: G645-G649, 1992.
47. Kato M, Kato Y, Nakamura T and Sugiyama Y: Efficient extraction by the liver governs overall elimination of hepatocyte growth factor in rats. J Pharmacol Exp Ther 290: 373-379, 1999.
48. Liu KX, Kato Y, Terasaki T, Aoki S, Okumura K, Nakamura T and Sugiyama Y: Contribution of parenchymal and non-parenchymal liver cells to the clearance of hepatocyte growth factor from the circulation in rats. Pharm Res 12: 1737-1740, 1995.
49. Liu KX, Kato Y, Kino I, Nakamura T and Sugiyama Y: Ligand-induced downregulation of receptor-mediated clearance of hepatocyte growth factor in rats. Am J Physiol 275: E835-E842, 1998.